ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

IOM Committee Advises DOD To Fund Grants; Training, Infrastrucure In Breast Cancer; Goals To Raise Number of New Investigators

May 21, 1993

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

January 24, 1986

DCPC Board approves New CCOP RFA Following Addition Of Public Health, Education Components

May 16, 1986

NCAB Sets Bypass Budget Figures at $1.074 Billion

May 28, 1982

Three researchers share Paul Marks Prize.

November 11, 2005